Opinion: Develop Organoids, Not Chimeras, for Transplantation

Scientists are devising human-animal hybrids for harvesting human organs, but lab-derived mini-organs are a less ethically fraught solution to meeting the need for transplantation.

Written byJohn D. Loike and Robert Pollack
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

R

ecent studies have shown that even though about 50 percent of adults in the United States have registered as organ donors, more than 100,000 people in the United States are waiting for a transplant, and many will die waiting. The increasing scarcity of human organ donors has driven research scientists to examine options other than donation from deceased patients, such as xenotransplantation, or the use of human organs that were grown in animals.

Xenotransplantation experiments are being conducted in sheep, pigs, and, most recently, in nonhuman primates. In July, a group of scientists from Spain and the US claimed to have successfully created embryos containing both monkey and human cells as a preliminary step in examining the use of such human-monkey chimeras as hosts to produce human organs. According to published reports, the research was conducted in China “to avoid legal issues.

Xenotransplantation experiments rely on applying gene editing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • John Loike

    John Loike serves as the interim director of bioethics at New York Medical College and as a professor of biology at Touro University. He served previously as the codirector for graduate studies in the Department of Physiology Cellular Biophysics and director of Special Programs in the Center for Bioethics at Columbia University College of Physicians and Surgeons. His biomedical research focuses on how human white blood cells combat infections and cancer. Loike lectures internationally on emerging topics in bioethics, organizes international conferences, and has published more than 150 papers and abstracts in the areas of immunology, cancer, and bioethics. He earned his Ph.D. from the Albert Einstein College of Medicine of Yeshiva University.

    View Full Profile
  • The Scientist Placeholder Image
    This person does not yet have a bio.View Full Profile

Published In

October 2019

Brain Fog

Air Pollution May Cause Cognitive Decline

Share
Image of small blue creatures called Nergals. Some have hearts above their heads, which signify friendship. There is one Nergal who is sneezing and losing health, which is denoted by minus one signs floating around it.
June 2025, Issue 1

Nergal Networks: Where Friendship Meets Infection

A citizen science game explores how social choices and networks can influence how an illness moves through a population.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

The Scientist Placeholder Image

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity 

The Scientist Placeholder Image

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series

agilent-logo

Agilent Announces the Enhanced 8850 Gas Chromatograph

parse-biosciences-logo

Pioneering Cancer Plasticity Atlas will help Predict Response to Cancer Therapies